9-valent HPV (9vHPV) Vaccine Program Safety and Immunogenicity Study in Women 27-45 Years

Luxembourg, Alain

i

9-valent HPV (9vHPV) Vaccine Program Safety and Immunogenicity Study in Women 27-45 Years

Public Domain

June 26. 2019
By Luxembourg, Alain
Series: ACIP: Human Papillomavirus (HPV)

File Language:

English

Details

Personal Author:

Luxembourg, Alain
Corporate Authors:

Merck Research Laboratories.
Subjects:

Papillomavirus Vaccines
Series:

ACIP: Human Papillomavirus (HPV)
Document Type:

Still Image
Name as Subject:

ACIP meeting: 2019 Jun ; ACIP meeting: 2019 Jun
Genre:

Presentation ; Conference Publications
Volume:

201902
Issue:

010103
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

urn:sha-512:c07aa0c7ed7ca6fb46cd2f26851024b04439a076dc498122c924d782568b25a4518704c2a09eeb489b59ca60792d061ea92c15eadab0f4348304ffae3ecfeb20
Download URL:

https://stacks.cdc.gov/view/cdc/82630/cdc_82630_DS1.pdf
File Type:

[PDF - 72.09 KB ]

File Language:

English

ON THIS PAGE

Details Related Documents

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.